MedTrace Logo

Sophisticated Assessment of Disease Burden in Patients With Fabry Disease

NCT01210196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2021-06-03

No results posted yet for this study

Summary

To detect early signs of cardiac and metabolic alterations as well as to evaluate the progression of cardiac and metabolic impairments in mildly affected patients with Fabry Disease using high sensitive diagnostic methods.

Conditions

Interventions

PROCEDURE

MRI

Cardiac MRI after 12 and 24 months.

Sponsors & Collaborators

  • Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01210196 on ClinicalTrials.gov